2019

1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

   Therapeutic Advances in Gastroenterology, Vol. 12

2. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

   Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500